around 200 million individuals. With only one set of eyes, an incurable condition signifies a permanent loss of sight. However, recent studies suggest the potential for those impacted by AMD to regain their vision. As reported in the New England Journal of Medicine, the study recommends a minuscule implant that delivers “clinically meaningful enhancements” to individuals enduring GA.
Named the photovoltaic retina implant microarray (PRIMA), this compact system employs a subretinal photovoltaic chip embedded in the eye, along with augmented reality glasses that emit near-infrared light, effectively restoring vision. Since individuals with dry AMD generally maintain some photoreceptor functionality, researchers exploited this by placing a light-sensitive device to enhance sight. The producer of the 2 mm implant has claimed it can restore vision, now supported by scientific validation. In conjunction with the chip, the augmented reality glasses — which link to a controller worn on the waist — capture visual data and transfer it to the implant as infrared light. Subsequently, AI processes these signals to convert them into brain-interpretable images. The findings indicate that 80% of participants experienced an improvement after one year, achieving partial vision restoration.
<div class="slide-key image-holder gallery-image-holder credit-image-wrap" data-post-url="https://www.bgr.com/2009241/how-electronic-eye-implant-restore-vision-age-related-macular-degeneration/" data-post-title="This Electronic Eye Implant Can Now Restore Vision For Some Patients" data-slide-num="1" data-post-id="200924
